Your search returned 26 studies. (Get alerts for new studies):
- Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail
Conditions: Onychomycosis of Toenails
Location: College Station, Texas
- Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus
Location: Katy, Texas
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Waller, Texas
- A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Conditions: Asthma
Location: Katy, Texas
- An Open-Label Study of Trastuzumab Emtansine (T-DM1) vs Capecitabine+Lapatinib in Patients With HER2-Positive Locally Advanced or Metastatic Breast Ca
Conditions: Breast Cancer
Location: Bryan, Texas
- An Open-Label Study of Trastuzumab Emtansine (T-DM1) vs Capecitabine+Lapatinib in Patients With HER2-Positive Locally Advanced or Metastatic Breast Ca
Conditions: Breast Cancer
Location: Bryan, Texas
- Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Conditions: Non-Small Cell Lung Cancer - Anemia - Cancer - Lung Cancer
Location: Bryan, Texas
- PAVES: Pegfilgrastim Anti-VEGF Evaluation Study
Conditions: Cancer - Colon Cancer - Colorectal Cancer - Fever - Locally Advanced - Metastatic Colorectal Cancer - Neutropenia - Rectal Cancer
Location: Bryan, Texas
- A Study of DER 45-EV Gel to Treat Rosacea
Conditions: Rosacea
Location: College Station, Texas
- College Students and Smoking Cessation
Conditions: Smoking Cessation - Habits - Smoking
Location: College Station, Texas
- Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Conditions: Chronic Lymphocytic Leukemia
Location: Bryan, Texas
- Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Conditions: Chronic Lymphocytic Leukemia
Location: College Station, Texas
- Connect® MM- The Multiple Myeloma Disease Registry
Conditions: Multiple Myeloma
Location: Bryan, Texas
- Connect® MM- The Multiple Myeloma Disease Registry
Conditions: Multiple Myeloma
Location: College Station, Texas
- A Surgical Approach to the Management of Type II Diabetes Mellitus in Patients With a BMI Between 25-35 kg/m2
Conditions: Type 2 Diabetes Mellitus
Location: Bellaire, Texas
- A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did
Conditions: Overactive Bladder - Bladder, Overactive - Overactive Urinary Bladder
Location: Bryan, Texas
- A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did
Conditions: Overactive Bladder - Bladder, Overactive - Overactive Urinary Bladder
Location: Bryan, Texas
- Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
Conditions: Rosacea
Location: College Station, Texas
- Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Conditions: ACE Inhibitor Induced Angioedema
Location: Bryan, Texas
- A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Conditions: Coronary Artery Disease
Location: Katy, Texas
- The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Conditions: Chronic Idiopathic Constipation
Location: Katy, Texas
- A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)
Conditions: Type 2 Diabetes Mellitus
Location: Katy, Texas
- Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens
Conditions: Myopia
Location: Katy, Texas
- Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypert
Conditions: Stage 1 Hypertension - Stage 2 Hypertension
Location: Bryan, Texas
- Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On M
Conditions: Diabetes Mellitus, Type 2
Location: Bryan, Texas
- Evaluate the Safety & Bioequivalence of a Generic Butenafine Cream & Lotrimin Ultra® & Compare Both to a Vehicle Control in Treatment of I
Conditions: Tinea Pedis
Location: College Station, Texas
|